Eiger BioPharmaceuticals (EIGR) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.57
-0.49
-0.4
-0.32

Details

Expected EPS
-0.32
Actual EPS
-0.41
Surprise EPS
-0.09
Surprise Percent
+28.12%

Description

Eiger BioPharmaceuticals (EIGR) has reported earnings of -0.41 per share for Q3 2023.

0 Comments

Share your thoughts